Bioventus BVS Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bioventus's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bioventus's additional paid-in capital?
- Bioventus (BVS) reported additional paid-in capital of $522.91M in Q1 2026.
- How has Bioventus's additional paid-in capital changed year-over-year?
- Bioventus's additional paid-in capital increased by 2.4% year-over-year, from $510.42M to $522.91M.
- What is the long-term trend for Bioventus's additional paid-in capital?
- Over 4 years (2021 to 2025), Bioventus's additional paid-in capital has grown at a 2.4% compound annual growth rate (CAGR), from $473.32M to $520.85M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.